zoledronsyre
Zoledronic acid, also known as zoledronsyre in Danish, is a bisphosphonate medication used primarily to treat and prevent osteoporosis, a condition characterized by weakened bones that can lead to fractures. It belongs to a class of drugs called nitrogen-containing bisphosphonates and works by inhibiting osteoclastic activity, which reduces bone breakdown and increases bone density.
Zoledronic acid is administered intravenously, typically in a hospital or clinic setting, and is usually given
Common side effects of zoledronic acid include injection site reactions, such as pain, redness, or swelling,
Zoledronic acid is contraindicated in patients with a history of osteonecrosis of the jaw, severe renal impairment,
Monitoring of bone mineral density and calcium levels is recommended during treatment with zoledronic acid. Regular
Zoledronic acid has been shown to be effective in increasing bone mineral density and reducing the risk